Lichen Planus

Pruritic, purple, plan-topped, polygonal, pappules involving mucosa and rarely with nail dystrophy & scaring alopecia, shows Wickham striae and Koebner phenomenon, treated with topical steroids(0.05% clobetasol) or oral prednisolone addon therapy with PUVA, retinoids, azathioprines

Dermatology Lichen Planus #lichen #planus #lichen planus #koebner #wickham
Lichen planus is a chronic pruritic self limiting inflammatory dermatosis that is commonly associated with mucosal involvement and rarely with nail dystrophy and scaring alopecia.

It usually involves flexor aspext of wrist adn lower legs. In mucosal involvement mouth, anogenital region, oesophagus.

Risk factors:
  • most imp: dental amalgum (due to mercury)
  • infection: hepatitis b & c
  • drugs like antimalaria, ACEIs, B-blockers

Etiopathogenesis:

It is T-cell driven immune mechanism. 

A mixed lymphohistiocytic infiltrate is seen at dermoepidermoid junction, which becomes ragged and saw-toothed. Basal layer shows liquefactive degeneration. Acanthosis and Hyperkeratosis of the epidermis.

 
Clinical Features:
  • tiny
  • pappule
  • pruritic
  • purple
  • plane-topped
  • polygonal
  • Wickham's striae: whitish linear streaks seen on surface under oil immersion field.
  • Koebner's phenomenon: aka isomorphic response, indicate active form, similar morphological lesion seen along lines of trauma 
  • Scaring alopecia in scalps
  • Nails may be dystrophic
  • Hyperpigmentation after resolution

Variants:

  • Atrophic
  • Hypertrophic
  • Annular

Investigation:

usually not done, but histopathology can be done which shows:
  • Hyperkeratosis: rover Stratum corneum
  • Wedge shaped hypergranulosis in St. granulosum
  • Saw-toothed rete ridge
  • Acanthosis: Thickening of the stratum spinosum
  • lyphocytic infiltrates in dermoepidermal junction
  • necrotic keratinocytes
  • basal cell degeneration
  • artefactual cleft at DEJ

Treatment:

General measures:
  • counseling, reassurance and emotional support
  • physical activity and metal rest is adjuvant

Specific measures:

  1. Topical : Clobetasol, intralesional steriods
  2. Systemic: oral prednisolone, methotrexate, dapsone
  3. Others: PUVA, retionoids, azathioprine

Comments

No comments yet. Be the first to comment.